Health state utilities for non small cell lung cancer

Health state utilities for non small cell lung cancer

<p>Abstract</p> <p>Background</p> <p>Existing reports of utility values for metastatic non-small cell lung cancer (NSCLC) vary quite widely and are not all suitable for use in submissions in the UK. The aim of this study was to elicit UK societal based utility values fo...

Full description

Bibliographic Details
Main Authors:	Bhalla Shkun, Gavriel Sonia, Stafford Megan, Nafees Beenish, Watkins Jessamy
Format:	Article
Language:	English
Published:	BMC 2008-10-01
Series:	Health and Quality of Life Outcomes
Online Access:	http://www.hqlo.com/content/6/1/84

Similar Items

Estimating health state utilities in hemophagocytic lymphohistiocytosis
by: Beenish Nafees, et al.
Published: (2021-01-01)

A Patient-Centered Utility Index for Non–Small Cell Lung Cancer in the United States
by: J. Shannon Swan, et al.
Published: (2018-10-01)

Clinical utility of ramucirumab in non-small-cell lung cancer
by: Uprety D
Published: (2019-07-01)

The Evolution of Therapies in Non-Small Cell Lung Cancer
by: Vishal Boolell, et al.
Published: (2015-09-01)

Clinical and comparative utility of afatinib in non-small cell lung cancer
by: D'Arcangelo M, et al.
Published: (2014-04-01)

Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients
by: Noman Paracha, et al.
Published: (2018-09-01)

Mechanisms of exertional dyspnea in postsurgical patients with non-small cell lung cancer
by: Harper, Megan
Published: (2015)

Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art
by: Jin Kang, et al.
Published: (2021-04-01)

Clinical utility of Circulating Tumor Cells in ALK-Positive Non-Small-Cell Lung Cancer
by: Vincent eFaugeroux, et al.
Published: (2014-11-01)

Proton beam therapy in non-small cell lung cancer: state of the art
by: Harada H, et al.
Published: (2017-08-01)

Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms
by: Megan B. Barnet, et al.
Published: (2018-06-01)

The utility of transbronchial rebiopsy for peripheral pulmonary lesions in patients with advanced non-squamous non-small cell lung cancer
by: Akiko Tateishi, et al.
Published: (2020-09-01)

Clinical utility of erlotinib for the treatment of non-small-cell lung cancer in Japanese patients: current evidence
by: Togashi Y, et al.
Published: (2014-07-01)

Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancer
by: Louise Turtle, et al.
Published: (2021-06-01)

Trends and characteristics of young non-small cell lung cancer patients in the United States
by: Anish eThomas, et al.
Published: (2015-05-01)

Stated Preferences in Non-Small-Cell Lung Cancer: A Discrete Choice Experiment
by: Meirelles I, et al.
Published: (2021-04-01)

Gefitinib in Non Small Cell Lung Cancer
by: Raffaele Costanzo, et al.
Published: (2011-01-01)

Prognostic analysis of non-small lung cancer
by: Qin WANG, et al.
Published: (2008-08-01)

RNAi and non-small cell lung cancer
by: Chunyu YANG, et al.
Published: (2008-08-01)

Angiogenesis and Non Small Cell Lung Cancer
by: Metodieva S
Published: (2008-01-01)

Disease severity-based evaluation of utility weights for lung cancer-related health states in Korea
by: Eun-Jung Kim, et al.
Published: (2018-11-01)

The utility of positron emission tomography in the treatment planning of image-guided radiotherapy for non-small cell lung cancer
by: Alexander eChi, et al.
Published: (2014-10-01)

Staging of nutrition disorders in non‐small‐cell lung cancer patients: utility of skeletal muscle mass assessment
by: Sami Antoun, et al.
Published: (2019-08-01)

Target Therapy, Medical Resource Utilization and Cost Effectiveness Analysis of Non-Small Cell Lung Cancer in Taiwan
by: Li-Kuei Wang, et al.
Published: (2010)

Utility of red cell distribution width as a diagnostic and prognostic marker in non-small cell lung cancer
by: Bin Song, et al.
Published: (2020-09-01)

Panel Data Opioid Utilization Analysis of Advanced Stage Non-Small Cell Lung Cancer Patients in Taiwan Cancer Centers
by: Jen-Kuei Peng, et al.
Published: (2008)

Efficacy of Lung Autotransplantation for Central Non-small Cell Lung Cancer
by: Yijun MO, et al.
Published: (2020-08-01)

Increased Expression and Activation of FAK in Small-Cell Lung Cancer Compared to Non-Small-Cell Lung Cancer
by: Frank Aboubakar Nana, et al.
Published: (2019-10-01)

Transformation of non-small cell lung cancer into small cell lung cancer in a patient with advanced lung cancer: a case report
by: Zhengyuan Yang, et al.
Published: (2021-08-01)

Cancer research on non-small cell lung cancer in smokers and non-smokers
by: William C.S. Cho
Published: (2009-10-01)

Prognosis of Different Types of Non-Small Cell Lung Cancer Progression: Current State and Perspectives
by: Anastasia A. Schegoleva, et al.
Published: (2021-03-01)

Surgical management of non-small-cell lung cancer
by: Bamousa Ahmed, et al.
Published: (2008-10-01)

Systemic therapy in non-small-cell lung cancer
by: Jazieh Abdul-Rahman, et al.
Published: (2008-10-01)

HYPERTHERMIA IN TREATMENT OF NON-SMALL CELL LUNG CANCER
by: А. Yu. Dobrodeev, et al.
Published: (2016-02-01)

Molecular profiling of non-small cell lung cancer.
by: Marika L Forsythe, et al.
Published: (2020-01-01)

Precision radiotherapy for non-small cell lung cancer
by: Wen-Chi Yang, et al.
Published: (2020-07-01)

Surgical treatment of non-small-cell lung cancer
by: Stefan B Watzka, et al.
Published: (2016-01-01)

Notch Transduction in Non-Small Cell Lung Cancer
by: Amnah Sharif, et al.
Published: (2020-08-01)

Advances in Immunotherapies for Non-small Cell Lung Cancer
by: Yuan HE, et al.
Published: (2014-03-01)

Application of Bevacizumab in Non-small Cell Lung Cancer
by: Ping XU, et al.
Published: (2017-04-01)